Literature DB >> 948149

Medication prescribing on a university medical service-the incidence of drug combinations with potential adverse interactions.

D W Simborg.   

Abstract

The medication prescribing practices on a University medical service were reviewed for a two year period. 103,484 medication orders were analyzed for 6,864 patient admissions. Forty drugs account for 64% of all medication orders. One hundred drugs account for 86% of all medication orders. During the two year period the incidence of prescribing specific drug combinations with potential adverse interactions varied from three to one hundred seventeen instances among the combinations examined. Review of a sample of those patients receiving the combination of spironolactone and oral potassium chloride showed that 52% developed hyperkalemia. These results suggest that when physicians prescribe drug combinations with potentially adverse interactions they may not always institute appropriate surveillance to prevent adverse consequences. A trial of automated monitoring of medication orders with appropriate physician feedback has begun as a result of these findings.

Entities:  

Mesh:

Year:  1976        PMID: 948149

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


  4 in total

1.  Will the wave finally break? A brief view of the adoption of electronic medical records in the United States.

Authors:  Eta S Berner; Don E Detmer; Donald Simborg
Journal:  J Am Med Inform Assoc       Date:  2004-10-18       Impact factor: 4.497

2.  Clinical pharmacology. Adverse drug interactions.

Authors:  J K Aronson; D G Grahame-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24

3.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Authors:  L Magro; A Conforti; F Del Zotti; R Leone; M L Iorio; I Meneghelli; D Massignani; E Visonà; U Moretti
Journal:  Eur J Clin Pharmacol       Date:  2007-11-09       Impact factor: 2.953

Review 4.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.